The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub

エピソード

sGC Modulators in HFrEF: MOA, Clinical Evidence, With Drs. IIeana Pina and Javed Butler
23 8月 2023· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss the mechanism of action of and clinical evidence for the use of soluble guanylate cyclase (sGC) modulators in heart failure with reduced ejection fraction (HFrEF).
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Updated Guidelines Recommendations for the Management of HFrEF and Worsening HF, With Drs. Ileana Pina and Shelley Zieroth
23 8月 2023· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss the updated guideline recommendations for the management of heart failure with reduced ejection fraction (HFrEF) and worsening HF.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
エピソードを見逃しましたか？

フィードを更新するにはここをクリックしてください。
Burden of HFrEF and Worsening HF, With Drs. Ileana Piña and Javed Butler
23 8月 2023· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss the burden of HFrEF and worsening HF.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera
2 6月 2022· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss evidence-based management of CV risk reduction.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub
2 6月 2022· MedEdTalks - Cardiology
Clinical Evidence for Omega-3 PUFAs for Managing CV Risk with Drs. Peter Toth and Pam Taub.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera
2 6月 2022· MedEdTalks - Cardiology
The Impact of Omega-3 PUFAs on CV Risk Reduction with Drs. Peter Toth and Amit Khera.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub
2 6月 2022· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss the role of inflammation in atherosclerosis.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll
27 4月 2022· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss management selection for embolic stroke with a PFO.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll
27 4月 2022· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss treatment options for embolic stroke due to a PFO.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner
27 4月 2022· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss the current guidelines for the management of embolic stroke with a PFO.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner
27 4月 2022· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss challenges in the diagnosis of embolic stroke with a PFO.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner
29 4月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians will share procedural pearls for PFO closure and important considerations to optimize patient outcomes.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner
29 4月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss management of patients with cryptogenic stroke as well as strategies for applying new guideline recommendations into practice.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner
29 4月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss the association between patent foramen ovale and stroke and review the current clinical data to support PFO closure.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner
29 4月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss strategies for classification and workup of cryptogenic stroke and PFO-associated stroke.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt
24 3月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss latest clinical evidence from cardiovascular outcomes trials and how reducing triglycerides for further reduces risk.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar
24 3月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss evidence regarding mitigating cardiovascular risk by LDL-C reduction.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Patient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha Gulati
24 3月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss secondary prevention and how to identify patients who may benefit from additional treatment to reduce CV risk.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha Gulati
24 3月 2021· MedEdTalks - Cardiology
In this podcast, expert clinicians discuss primary prevention as well as strategies for ASCVD risk assessment.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler
16 12月 2020· MedEdTalks - Cardiology
In this podcast, expert clinicians will discuss the potential use of sGC modulators in the management of patients with heart failure with reduced ejection fraction (HFrEF).
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
もっと表示する

エピソード

sGC Modulators in HFrEF: MOA, Clinical Evidence, With Drs. IIeana Pina and Javed Butler

Updated Guidelines Recommendations for the Management of HFrEF and Worsening HF, With Drs. Ileana Pina and Shelley Zieroth

Burden of HFrEF and Worsening HF, With Drs. Ileana Piña and Javed Butler

Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera

Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub

The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera

Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll

Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll

Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner

Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner

PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner

Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner

The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner

Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner

Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt

Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar

Patient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha Gulati

Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha Gulati

sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler